首页> 美国政府科技报告 >Morbidity and Mortality Weekly Report, Vol 54, No. RR-2 Recommendations and Reports, January 21, 2005. Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States
【24h】

Morbidity and Mortality Weekly Report, Vol 54, No. RR-2 Recommendations and Reports, January 21, 2005. Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States

机译:发病率和死亡率每周报告,第54卷,第RR-2号建议和报告,2005年1月21日。在美国进行性,注射吸毒或其他非职业性接触艾滋病毒后的抗逆转录病毒暴露后预防

获取原文

摘要

The most effective means of preventing human immunodeficiency virus (HIV) infection is preventing exposure. The provision of antiretroviral drugs to prevent HIV infection after unanticipated sexual or injection-drug use exposure might be beneficial. The U.S. Department of Health and Human Services (DHHS) Working Group on Nonoccupational Postexposure Prophylaxis (nPEP) made the following recommendations for the United States. For persons seeking care

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号